Bill > HR6283

This bill, the Delinking Revenue from Unfair Gouging Act (DRUG Act), aims to improve the services provided by pharmacy benefit managers (PBMs). The key provisions of the bill are: 1. PBMs will not be allowed to derive any remuneration from entities for services, benefit administration, or other activities related to prescription drugs, except for bona fide service fees that are a flat dollar amount and not based on drug prices, discounts, or other prohibited amounts. 2. PBMs are prohibited from engaging in certain practices, such as charging health plans or insurers a different amount for a drug's ingredient cost or dispensing fee compared to what they reimburse the pharmacy, or reimbursing network pharmacies at a lower rate than their own affiliated pharmacies. 3. The bill also prohibits PBMs from steering patients to use pharmacies owned, controlled, or affiliated with the PBM through various means, such as benefit designs that increase costs for patients who don't use the PBM's affiliated pharmacies. 4. The Secretaries of Health and Human Services, Labor, and the Treasury (or the Office of Personnel Management for the Federal Employees Health Benefits Program) will enforce the provisions of the bill and can impose civil monetary penalties for violations. The overall goal of the bill is to increase transparency and accountability in the PBM industry, and to prevent PBMs from engaging in practices that may lead to higher drug costs for patients and health plans.